ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

RPTX Repare Therapeutics Inc

3,45
0,10 (2,99%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Repare Therapeutics Inc RPTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,10 2,99% 3,45 06:00:07
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,48 3,445 3,74 3,45 3,35
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202413:05BWDEBIOPHARM ET REPARE THERAPEUTICS ANNONCENT LE TRAITEMENT..
26.4.202422:05BWRepare Therapeutics Appoints Steven H. Stein, M.D. to its..
05.3.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202403:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202413:05BWRepare Therapeutics to Participate in Two Upcoming Investor..
28.2.202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
28.2.202413:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28.2.202413:10EDGAR2Form 8-K - Current report
28.2.202413:05BWRepare Therapeutics Provides Business Update and Reports..
15.2.202413:05BWRepare Therapeutics Doses First Patient in Phase 1 Clinical..
15.2.202403:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202414:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202422:48EDGAR2Form 8-K - Current report
12.2.202422:05BWRepare Therapeutics to Regain Global Rights to Camonsertib
25.1.202420:29EDGAR2Form 8-K - Current report
25.1.202413:00BWRepare Therapeutics Announces Achievement of $40 Million..
12.1.202422:05EDGAR2Form 8-K - Current report
08.1.202413:00BWRepare Therapeutics Provides Corporate Update and Highlights..
04.1.202422:05BWRepare Therapeutics and Debiopharm Partner to Explore the..
29.12.202322:05BWRepare Therapeutics Insiders Establish Automatic Securities..
12.12.202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202313:20EDGAR2Form 8-K - Current report
15.11.202313:00BWRepare Therapeutics Unveils Two Programs Expected to Enter..
09.11.202313:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202313:05EDGAR2Form 8-K - Current report
09.11.202313:00BWRepare Therapeutics Provides Business Update and Reports..
07.11.202313:00BWRepare Therapeutics to Host Investor and Analyst Conference..
06.11.202313:00BWRepare Therapeutics to Participate in Two Upcoming Investor..
13.10.202323:15EDGAR2Form 8-K - Current report
13.10.202315:47EDGAR2Form 8-K - Current report
13.10.202315:40BWRepare Therapeutics Announces Positive Initial Data from..
06.10.202313:56EDGAR2Form 8-K - Current report
03.10.202313:00BWRepare Therapeutics to Host Conference Call and Webcast to..
19.9.202313:00BWRepare Therapeutics to Present Preliminary Phase 1 MYTHIC..
06.9.202313:00BWRepare Therapeutics to Participate at the Morgan Stanley..
09.8.202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:09EDGAR2Form 8-K - Current report
09.8.202322:05BWRepare Therapeutics Provides Business Update and Reports..
08.6.202313:00BWRepare Therapeutics to Participate at the Goldman Sachs 44th..
07.6.202322:05BWRepare Therapeutics Reports Proof of Concept for Lunresertib..
06.6.202313:00BWRepare Therapeutics Announces Publication in Nature Medicine..
02.6.202313:00BWRepare Therapeutics to Host Conference Call and Webcast to..
22.5.202313:00BWRepare Reports Inducement Grant Under Nasdaq Listing Rule..
09.5.202322:05BWRepare Therapeutics Provides Business Update and Reports..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock